Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 6429812, 9 pages
http://dx.doi.org/10.1155/2016/6429812
Research Article

Can Breast Tumors Affect the Oxidative Status of the Surrounding Environment? A Comparative Analysis among Cancerous Breast, Mammary Adjacent Tissue, and Plasma

1Laboratory of Inflammatory Mediators, State University of West Paraná (UNIOESTE), Campus Francisco Beltrão, 85605-010 Francisco Beltrão, PR, Brazil
2School of Medicine, State University of Sao Paulo (USP), 07112-000 São Paulo, SP, Brazil
3School of Medicine, Pontifícia Universidade Católica (PUC), Campus Londrina, 86051-990 Londrina, PR, Brazil
4Laboratory of Physiopathology and Free Radicals, Department of General Pathology, State University of Londrina (UEL), 86051-990 Londrina, PR, Brazil
5University Hospital, Department of Pharmacy, State University of Londrina (UEL), 86051-990 Londrina, PR, Brazil
6Department of Preventive Medicine, Federal University of São Paulo (UNIFESP), 07112-000 São Paulo, SP, Brazil

Received 22 May 2015; Revised 4 August 2015; Accepted 12 August 2015

Academic Editor: Manoj K. Pandey

Copyright © 2016 C. Panis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Ogura and T. Shimosawa, “Oxidative stress and organ damages,” Current Hypertension Reports, vol. 16, no. 8, article 452, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. A. R. Nourazarian, P. Kangari, and A. Salmaninejad, “Roles of oxidative stress in the development and progression of breast cancer,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 12, pp. 4745–4751, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Landskron, M. De La Fuente, P. Thuwajit, C. Thuwajit, and M. A. Hermoso, “Chronic inflammation and cytokines in the tumor microenvironment,” Journal of Immunology Research, vol. 2014, Article ID 149185, 19 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Halliwell, “Oxidative stress and cancer: have we moved forward?” Biochemical Journal, vol. 401, no. 1, pp. 1–11, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Toyokuni, K. Okamoto, J. Yodoi, and H. Hiai, “Persistent oxidative stress in cancer,” FEBS Letters, vol. 358, no. 1, pp. 1–3, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. P. K. Mahalingaiah and K. P. Singh, “Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells,” PLoS ONE, vol. 9, no. 1, Article ID e87371, 2014. View at Publisher · View at Google Scholar
  7. D. C. Malins and R. Haimanot, “Major alterations in the nucleotide structure of DNA in cancer of the female breast,” Cancer Research, vol. 51, no. 19, pp. 5430–5432, 1991. View at Google Scholar · View at Scopus
  8. C. Yau and C. C. Benz, “Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers,” Breast Cancer Research, vol. 10, no. 4, article R61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. V. J. Victorino, F. C. Campos, A. C. S. A. Herrera et al., “Overexpression of HER-2/neu protein attenuates the oxidative systemic profile in women diagnosed with breast cancer,” Tumor Biology, vol. 35, no. 4, pp. 3025–3034, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. A. C. S. A. Herrera, C. Panis, V. J. Victorino et al., “Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients,” Cancer Immunology, Immunotherapy, vol. 61, no. 11, pp. 2193–2201, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Panis, V. J. Victorino, A. C. S. A. Herrera et al., “Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer,” Breast Cancer Research and Treatment, vol. 133, no. 3, pp. 881–888, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. D. G. Altman, L. M. McShane, W. Sauerbrei, and S. E. Taube, “Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration,” PLoS Medicine, vol. 9, no. 5, Article ID e1001216, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Fernández-Durango, A. Fernández-Martínez, J. García-Feijoo et al., “Expression of nitrotyrosine and oxidative consequences in the trabecular meshwork of patients with primary open-angle glaucoma,” Investigative Ophthalmology and Visual Science, vol. 49, no. 6, pp. 2506–2511, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Panis, A. C. S. A. Herrera, V. J. Victorino et al., “Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy,” Breast Cancer Research and Treatment, vol. 133, no. 1, pp. 89–97, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. V. J. Victorino, C. Panis, F. C. Campos et al., “Decreased oxidant profile and increased antioxidant capacity in naturally postmenopausal women,” Age, vol. 35, no. 4, pp. 1411–1421, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. A. C. S. Herrera, V. J. Victorino, F. C. Campos et al., “Impact of tumor removal on the systemic oxidative profile of patients with breast cancer discloses lipid peroxidation at diagnosis as a putative marker of disease recurrence,” Clinical Breast Cancer, vol. 14, no. 6, pp. 451–459, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. L. G. Lemos, V. J. Victorino, A. C. Herrera et al., “Trastuzumab-based chemotherapy modulates systemic redox homeostasis in women with HER2-positive breast cancer,” International Immunopharmacology, vol. 27, no. 1, pp. 8–14, 2015. View at Publisher · View at Google Scholar
  18. C. Panis, L. G. T. Lemos, V. J. Victorino et al., “Immunological effects of taxol and adryamicin in breast cancer patients,” Cancer Immunology, Immunotherapy, vol. 61, no. 4, pp. 481–488, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Mannello, G. A. Tonti, A. Pederzoli, P. Simone, A. Smaniotto, and V. Medda, “Detection of superoxide dismutase-1 in nipple aspirate fluids: a reactive oxygen species-regulating enzyme in the breast cancer microenvironment,” Clinical Breast Cancer, vol. 10, no. 3, pp. 238–245, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. J. M. Hartikainen, M. Tengström, R. Winqvist et al., “KEAP1 genetic polymorphisms associate with breast cancer risk and survival outcomes,” Clinical Cancer Research, vol. 21, no. 7, pp. 1591–1601, 2015. View at Publisher · View at Google Scholar
  21. E. Niki, “Lipid peroxidation: physiological levels and dual biological effects,” Free Radical Biology and Medicine, vol. 47, no. 5, pp. 469–484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Catalá, “Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions,” Chemistry and Physics of Lipids, vol. 157, no. 1, pp. 1–11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. A. N. C. Simão, A. A. Suzukawa, M. F. Casado, R. D. Oliveira, F. A. Guarnier, and R. Cecchini, “Genistein abrogates pre-hemolytic and oxidative stress damage induced by 2,2′-Azobis (Amidinopropane),” Life Sciences, vol. 78, no. 11, pp. 1202–1210, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Mannello, G. A. M. Tonti, S. Pagliarani et al., “The 8-epimer of prostaglandin F2α, a marker of lipid peroxidation and oxidative stress, is decreased in the nipple aspirate fluid of women with breast cancer,” International Journal of Cancer, vol. 120, no. 9, pp. 1971–1976, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. K. S. Fritz and D. R. Petersen, “An overview of the chemistry and biology of reactive aldehydes,” Free Radical Biology and Medicine, vol. 59, pp. 85–91, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Bauer, “Targeting extracellular ROS signaling of tumor cells,” Anticancer Research, vol. 34, no. 4, pp. 1467–1482, 2014. View at Google Scholar · View at Scopus
  27. O. O. Erejuwa, S. A. Sulaiman, and M. S. Ab Wahab, “Evidence in support of potential applications of lipid peroxidation products in cancer treatment,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 931251, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Panis, “Unraveling oxidation-induced modifications in proteins by proteomics,” Advances in Protein Chemistry and Structural Biology, vol. 94, pp. 19–38, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Guéraud, M. Atalay, N. Bresgen et al., “Chemistry and biochemistry of lipid peroxidation products,” Free Radical Research, vol. 44, no. 10, pp. 1098–1124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. R. M. Domingues, P. Domingues, T. Melo, D. Pérez-Sala, A. Reis, and C. M. Spickett, “Lipoxidation adducts with peptides and proteins: deleterious modifications or signaling mechanisms?” Journal of Proteomics, vol. 92, pp. 110–131, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Mannello, G. A. Tonti, and V. Medda, “Protein oxidation in breast microenvironment: nipple aspirate fluid collected from breast cancer women contains increased protein carbonyl concentration,” Cellular Oncology, vol. 31, no. 5, pp. 383–392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Olas, “Hydrogen sulfide in signaling pathways,” Clinica Chimica Acta, vol. 439, pp. 212–218, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Sibrian-Vazquez, J. O. Escobedo, S. Lim, G. K. Samoei, and R. M. Strongin, “Homocystamides promote free-radical and oxidative damage to proteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 2, pp. 551–554, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Mannello, D. Ligi, and M. Canale, “Aluminium, carbonyls and cytokines in human nipple aspirate fluids: possible relationship between inflammation, oxidative stress and breast cancer microenvironment,” Journal of Inorganic Biochemistry, vol. 128, pp. 250–256, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Ferroni, R. Palmirotta, F. Martini et al., “Determinants of homocysteine levels in colorectal and breast cancer patients,” Anticancer Research, vol. 29, no. 10, pp. 4131–4138, 2009. View at Google Scholar · View at Scopus
  36. S. Loibl, J. Bratengeier, V. Farines et al., “Investigations on the inducible and endothelial nitric oxide synthases in human breast cancer cell line MCF-7—estrogen has an influence on e-NOS, but not on i-NOS,” Pathology Research and Practice, vol. 202, no. 1, pp. 1–7, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Mehlen, C. Kretz-Remy, J. Briolay, P. Fostan, M.-E. Mirault, and A.-P. Arrigo, “Intracellular reactive oxygen species as apparent modulators of heat-shock protein 27 (hsp27) structural organization and phosphorylation in basal and tumour necrosis factor α-treated T47D human carcinoma cells,” Biochemical Journal, vol. 312, part 2, pp. 367–375, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. U. E. Martinez-Outschoorn, S. Pavlides, A. Howell et al., “Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment,” International Journal of Biochemistry and Cell Biology, vol. 43, no. 7, pp. 1045–1051, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Jezierska-Drutel, S. A. Rosenzweig, and C. A. Neumann, “Role of oxidative stress and the microenvironment in breast cancer development and progression,” in Advances in Cancer Research, vol. 119, chapter 3, pp. 107–125, Elsevier, 2013. View at Publisher · View at Google Scholar
  40. U. Martinez-Outschoorn, F. Sotgia, and M. P. Lisanti, “Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function,” Seminars in Oncology, vol. 41, no. 2, pp. 195–216, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Mencalha, V. J. Victorino, R. Cecchini, and C. Panis, “Mapping oxidative changes in breast cancer: understanding the basic to reach the clinics,” Anticancer Research, vol. 34, no. 3, pp. 1127–1140, 2014. View at Google Scholar · View at Scopus